GlobeNewsWire
13 Jun 2026, 02:00 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
The offering involved the sale of nearly 3.88 million shares of common stock and associated preferred investment options at $1.03 per share. — The issuance of millions of new shares and warrants creates significant equity dilution for existing shareholders.
-0.30Arcadia Biosciences closed a private placement raising approximately $4 million in gross proceeds. — Increases the company's cash runway for working capital, reducing immediate liquidity risk.
+0.20Which stocks this story touches
The company successfully closed a $4 million private placement to fund working capital and general corporate purposes.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
8h ago
